Research use only, not for human consumption. Email [email protected]
Research tools

Research status explorer

See where each compound sits in published research and clinical development. This describes the molecule’s research history — not the regulatory status of any Vital Edge Science product, and not a recommendation, efficacy claim or dosing guidance.

CompoundResearch lineResearch statusDevelopment note
5-Amino-1MQ Ignite Preclinical Cellular and animal research View →
BPC-157 Rebuild Preclinical Predominantly preclinical research View →
CJC-1295 Peak Human Research Early/historical clinical research View →
Cagrilintide Ignite Phase 3 Active clinical development View →
DSIP Neuro Human Research Historical human research View →
Epithalon Rebuild Human Research Limited/historical human research View →
GHK-Cu Rebuild Human Research Translational/human research View →
GHRP-2 Peak Human Research Experimental endocrine research View →
Glutathione Rebuild Human Research Extensive human literature View →
HCG Ignite Approved Molecule* Established medicine View →
Ipamorelin Peak Human Research Human pharmacology/clinical research View →
KPV Rebuild Preclinical Cellular and animal research View →
Kisspeptin-10 Enhance Human Research Active experimental human research View →
MOTS-c Ignite Phase 2a Early clinical investigation View →
Melanotan I Enhance Approved Molecule* Established pharmaceutical ingredient View →
Melanotan II Enhance Human Research Early/historical human research View →
NAD+ Ignite Human Research Broad translational research View →
PT-141 Enhance Approved Molecule* Established pharmaceutical ingredient View →
Retatrutide Ignite Phase 3 Active clinical development View →
SS-31 Rebuild Approved Molecule* Accelerated approval / confirmatory research ongoing View →
Selank Neuro Human Research Limited/regional clinical research View →
Semaglutide Ignite Approved Molecule* Extensive clinical development View →
Semax Neuro Human Research Limited/regional clinical research View →
Sermorelin Peak Human Research Extensive historical human research View →
Tesamorelin Peak Approved Molecule* Established pharmaceutical ingredient View →
Thymosin Alpha-1 Rebuild Phase 3 Indication-specific clinical development View →
Thymosin Beta-4 (TB-4) Rebuild Phase 2 Human clinical research View →
Tirzepatide Ignite Approved Molecule* Ongoing clinical research View →
5-Amino-1MQ
Ignite / Metabolic
Preclinical

Cellular and animal research

View research →
BPC-157
Rebuild / Repair & longevity
Preclinical

Predominantly preclinical research

View research →
CJC-1295
Peak / Growth axis
Human Research

Early/historical clinical research

View research →
Cagrilintide
Ignite / Metabolic
Phase 3

Active clinical development

View research →
DSIP
Neuro / Cognitive
Human Research

Historical human research

View research →
Epithalon
Rebuild / Repair & longevity
Human Research

Limited/historical human research

View research →
GHK-Cu
Rebuild / Repair & longevity
Human Research

Translational/human research

View research →
GHRP-2
Peak / Growth axis
Human Research

Experimental endocrine research

View research →
Glutathione
Rebuild / Repair & longevity
Human Research

Extensive human literature

View research →
HCG
Ignite / Metabolic
Approved Molecule*

Established medicine

View research →
Ipamorelin
Peak / Growth axis
Human Research

Human pharmacology/clinical research

View research →
KPV
Rebuild / Repair & longevity
Preclinical

Cellular and animal research

View research →
Kisspeptin-10
Enhance / Reproductive & pigmentation
Human Research

Active experimental human research

View research →
MOTS-c
Ignite / Metabolic
Phase 2a

Early clinical investigation

View research →
Melanotan I
Enhance / Reproductive & pigmentation
Approved Molecule*

Established pharmaceutical ingredient

View research →
Melanotan II
Enhance / Reproductive & pigmentation
Human Research

Early/historical human research

View research →
NAD+
Ignite / Metabolic
Human Research

Broad translational research

View research →
PT-141
Enhance / Reproductive & pigmentation
Approved Molecule*

Established pharmaceutical ingredient

View research →
Retatrutide
Ignite / Metabolic
Phase 3

Active clinical development

View research →
SS-31
Rebuild / Repair & longevity
Approved Molecule*

Accelerated approval / confirmatory research ongoing

View research →
Selank
Neuro / Cognitive
Human Research

Limited/regional clinical research

View research →
Semaglutide
Ignite / Metabolic
Approved Molecule*

Extensive clinical development

View research →
Semax
Neuro / Cognitive
Human Research

Limited/regional clinical research

View research →
Sermorelin
Peak / Growth axis
Human Research

Extensive historical human research

View research →
Tesamorelin
Peak / Growth axis
Approved Molecule*

Established pharmaceutical ingredient

View research →
Thymosin Alpha-1
Rebuild / Repair & longevity
Phase 3

Indication-specific clinical development

View research →
Thymosin Beta-4 (TB-4)
Rebuild / Repair & longevity
Phase 2

Human clinical research

View research →
Tirzepatide
Ignite / Metabolic
Approved Molecule*

Ongoing clinical research

View research →

*Approval refers to specific pharmaceutical products, formulations, jurisdictions and indications containing this molecule. It does not indicate that the Vital Edge Science research product is approved.